Kotopounga primary school
Natitingou, Atakora Department, Benin
NCT Number: NCT01790321
The general objective of this study is to determine the effect of the daily consumption of zinc-fortified water provided by the LSF-filter on zinc status and diarrhea rates in school age children from rural areas characterized by a high risk of zinc deficiency and by elevated stunting prevalence.
Looking for future studies?
Notify Me6 year–10 year
All sexes
Interventional
Not applicable
Natitingou, Atakora Department, Benin
A double-blind efficacy study will be carried out over 4 months in school age children enrolled in a primary school equipped with a water pump, in the rural area of the commune of Natitingou, Benin. Participating children will be randomly assigned to one of two groups of intervention or control. On a daily basis, all children will consume a defined quantity of pump-water outside of meals. The water offered to children in the first group of intervention will be previously filtered and zinc-fortified by the LSF-filter; the children in the second group will receive water that has been filtered only. A nutrition survey will provide an indication of dietary zinc intake. The effect of enriched water consumption on children's zinc status will be evaluated by analyzing the concentration of zinc in serum at baseline, midpoint and endpoint of the intervention. Diarrhea rates will be monitored by recording episodes of diarrhea.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
LifeStraw Family is a water purification device that by means of hollow fibres removes solid particles (<0.5 NTU turbidity reduction), bacteria (>Log 6 reduction), viruses (>Log 4 reduction) and cysts (>Log 3 reduction). Zinc fortification is provided by a chamber housing a zinc releasing glass-plate that is placed annexed to the hollow fibre column. It is estimated that the LSF can provide about 5 mg of zinc/l of filtered water. By consuming daily a portion of 0.6 litres of enriched water, >100% of the age-specific estimated physiologic requirement would be covered, assuming a fractional absorption of 40%.
Other names: LifeStraw Family by Vestergaard Frandsen SA
Time frame: Baseline, midpont (varying between weeks 5-20), endpoint (week 22)
Serum zinc concentration
Time frame: Baseline, midpoint (varying between weeks 5-20), endpoint (week 22)
Concentration of CRP in serum
Time frame: Baseline, midpoint (varying between weeks 5-20), endpoint (week 22)
Haemoglobin level
Time frame: Weekly, from baseline through to endpoint
Occurrence of diarrhea episodes monitored over 2 days weekly
Time frame: Baseline, midpoint (varying between weeks 5-20), endpoint (week 22)
Screening of HRP-II antigen
Time frame: At baseline and endpoint
Auscultation and respiratory frequence (no. of chest movements per minute)
Time frame: Baseline, midpoint (varying between weeks 5-20), endpoint (week 22)
Measurement of height, weight and mid-upper arm circumference for the assessment of height-for-age, weight-for-age and BMI-for-age Z-scores.
Prof. Michael B. Zimmermann
Other
Efficacy Study of Water as Fortification Vehicle for Zinc for Improving Zinc Status in Primary Schools Children in the Municipality of Natitingou, North of Benin.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585318
Child Nutrition Disorders, Iron Deficiencies
Guatemala City, Departamento de Guatemala, Guatemala
View Trial DetailsNCT02233764
Iron Deficiencies, Iron Deficiency
Bengaluru, Karnataka, India
View Trial DetailsNCT05085834
Cardiovascular Diseases, Inflammation
Cleveland, Ohio, United States
View Trial DetailsNCT03283813
Body Weight, Glucose Metabolism Disorders
Novara, Italy
View Trial Details